Clinical Trial: A Study of KCT-0809 in Patients With Dry Eye Syndromes

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized, Double Blind, Placebo Controlled, Exploratory Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.

Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.

Current Primary Outcome: Corneal-conjunctival staining scores [ Time Frame: 4 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Kissei Pharmaceutical Co., Ltd.

Dates:
Date Received: September 26, 2010
Date Started:
Date Completion:
Last Updated: June 30, 2011
Last Verified: June 2011